Effects of Sildenafil on Pulmonary Arterial Pressure in Patients With Heart Failure With Preserved Ejection Fraction ( HFpEF) and Pulmonary Hypertension
Phase of Trial: Phase III
Latest Information Update: 12 Nov 2016
Price : $35 *
At a glance
- Drugs Sildenafil (Primary)
- Indications Diastolic heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- 12 Nov 2016 Results published in the European Journal of Heart Failure
- 02 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Sep 2014 Planned End Date changed from 1 Jun 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov record.